Management of Hypertension with Conventional and Herbals Drugs

  • , Marjina Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India
  • Amandeep Singh Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India
  • Amit Sharma Department of Pharmacy practice, ISF College of Pharmacy, Moga-142001, Punjab, India
  • Raj Kumar Narang Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India
  • Gurmeet Singh Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Abstract

In this article, we have discussed about Types (primary, secondary, isolated, white coat, malignant, resistant and pulmonary hypertension), classification, adverse drug reactions of antihypertensive drugs (beta-blocker induce psoriasis and calcium channel blocker cause peripheral oedema. ACE inhibitor produce ankle oedema and thiazide diuretics causes hypenatremia and also hyperglycaemia. These are some of the serious adverse drug reactions associated with patients who are being treated with these drugs), measurement, management, diagnosis and associated diseases (e.g. diabetes mellitus, heart disease, cerebrovascular disease) lastly concluded about the herbal approach for management of hypertension  .


Keywords: Hypertension, conventional drugs, Herbal drugs

Keywords: Hypertension, conventional drugs, Herbal drug.

Downloads

Download data is not yet available.

Author Biographies

, Marjina, Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Amandeep Singh, Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Amit Sharma, Department of Pharmacy practice, ISF College of Pharmacy, Moga-142001, Punjab, India

Department of Pharmacy practice, ISF College of Pharmacy, Moga-142001, Punjab, India

Raj Kumar Narang, Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Gurmeet Singh, Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

Department of Pharmaceutics, ISF College of Pharmacy, Moga-142001, Punjab, India

References

1. Kishore J. Gupta N. Kohli C. Kumar N. Prevalence of hypertension and determination of its risk factors in rural Delhi. International journal of hypertension. 2016.
2. Bell K. Twiggs J. Bernie R. Hypertension: The Silent Killer: Updated JNC-8 Guideline. Harrison School of Pharmacy, Auburn University, Alabama Pharmacy Association. 2015.
3. Tain YL. Lin YJ. Sheen JM. Lin IC. Yu HR. Huang LT. Hsu CN. Resveratrol prevents the combined maternal plus postweaning high-fat-diets-induced hypertension in male offspring. The Journal of nutritional biochemistry. 2017; 1(48):120-7.
4. Joseph P. Leong D. McKee M. Anand SS. Schwalm JD. Teo K. Mente A. Yusuf S. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circulation research. 2017; 121(6):677-94.
5. Brown D. Edwards H. Seaton L. Buckley T. Lewis's Medical-surgical Nursing: Assessment and Management of Clinical Problems. Elsevier Health Sciences; 2017; 25.
6. Gredic M. Blanco I. Kovacs G. Helyes Z. Ferdinandy P. Olschewski H. Barberà JA. Weissmann N. Pulmonary hypertension in chronic obstructive pulmonary.
7. Izzo R. Patient with Essential Hypertension and Left Ventricular Enlargement. InHypertension and Cardiac Organ Damage 2017. 61-73.
8. Ripley TL. and Anna Barbato, Pharm. D., BCPS, AHSCP-CHC.
9. Sudhakar R. George MK. Yasaswini B. Sundararajan . Mariyam AS. Adverse drug reactions associated with anti-hypertensive drugs and its management. International Journal of Pharmaceutical Sciences and Research. 2016; 7(3):898.
10. O'Brien E. Asmar R. Beilin L. Imai Y.Mancia G. Mengden T. Myers M. Padfield P. Palatini P. Parati G. Pickering T. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. Journal of hypertension. 2005; 23(4):697-701.
11. Verma S. Chan LL. Chee KS. Chen H. Chin SA. Chong SA. Chua W. Fones C. Fung D. Khoo CL. Kwek SK. Corrigendum. Ministry of health clinical practice guidelines: schizophrenia.
12. Bathgate CJ. Fernandez-Mendoza J.Insomnia, short sleep duration, and high blood pressure: recent evidence and future directions for the prevention and management of hypertension. Current hypertension reports. 2018; 20(6):52.
13. Siu AL. Screening for high blood pressure in adults: US Preventive Services Task Force recommendation statement. Annals of internal medicine. 2015; 163(10):778-86.
14. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. CG 127.
15. Bialy LP. Wojcik C. Mlynarczuk-Bialy I. Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice. Biomedical Papers. 2018; 162(2):71-8.
16. Sharma M. Sharma R. Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica. 2016.
17. Sharma M. Sharma R. Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica. 2016; 2016.
18. Deng Y. Zhang X. Shen H. He Q. Wu Z. Liao W. Yuan M. Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases. Frontiers in Bioengineering and Biotechnology. 2019; 7.
19. Khan AR. Liu M. Khan MW. Zhai G. Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release. 2017; 268:364-89.
20. Neeharika MS. Jyothi BJ. Chronotherapeutics: an optimizing approach to synchronize drug delivery with circadian rhythm. Journal of Critical Reviews. 2015; 2(4):31-40.
21. Alam T. Khan S. Gaba B. Haider MF. Baboota S. Ali J. Nanocarriers as treatment modalities for hypertension. Drug delivery. 2017; 24(1):358-69.
22. Lewis RS. Deen WM. Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. Chemical research in toxicology. 1994; 7(4):568-74.
23. Nisar B.Sultan A. Rubab SL. Comparison of medicinally important natural products versus synthetic drugs-a short commentary. Nat Prod Chem Res. 2017; 6(308):2.
24. Koka JA. Bhat MY. Wani AH. Allelopathic effect of leaf extracts of Punica granatum and Spiraea prunifolia against post-harvest rot of tomato and brinjal. Journal of Drug Delivery and Therapeutics. 2020; 10(2-s):1-6.
25. Agrawal M. Nandini D. Sharma V. Chauhan NS. Herbal remedies for treatment of hypertension. Int J Pharm Sci and Res. 2010; 1(5):1-21.
26. Chrysant SG. Chrysant GS. Herbs used for the treatment of hypertension and their mechanism of action. Current hypertension reports. 2017; 19(9):77.
Statistics
54 Views | 34 Downloads
How to Cite
1.
Marjina , Singh A, Sharma A, Narang RK, Singh G. Management of Hypertension with Conventional and Herbals Drugs. JDDT [Internet]. 15May2020 [cited 6Jun.2020];10(3):280-7. Available from: http://jddtonline.info/index.php/jddt/article/view/3998

Most read articles by the same author(s)